The "new therapy" aimed at treating Alzheimer's disease such as Alzheimer is accelerating the pace of development. Regarding head ultrasound therapy, the final clinical trials will be launched in Japan in 2022. Stem cell nerve regeneration technology also shows the possibility of obtaining treatment. Both therapeutic mechanisms of the two therapies are different from the United States Biogen and Japanese guards in 2021 to obtain conditional approval drugs in the United States. The goal is to achieve fundamental treatment. The development of Alzheimer's ultrasonic therapy is Sound Wave Innovat... |